Rolf Turk
6PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 05, 2023
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.Jingyu Xiang, Jessica M Devenport, Alun J Carter
|Oct 01, 2021
Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair.Mollie S Schubert, Bernice Thommandru, Jessica Woodley
|Jul 20, 2021
Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.Liyang Zhang, John A Zuris, Ramya Viswanathan
|Jun 24, 2021
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.Liyang Zhang, John A Zuris, Ramya Viswanathan
|Aug 08, 2018
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells.Christopher A Vakulskas, Daniel P Dever, Garrett R Rettig
|Aug 02, 2017
Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development.Reena Clements, Rolf Turk, Kevin P Campbell
Pageof 1
Frequent Collaborators
3 joint publications
Christopher A Vakulskas
3 joint publications
Nicole M Bode
3 joint publications
Mark A Behlke
2 joint publications
Gavin L Kurgan
2 joint publications
Garrett R Rettig
2 joint publications
Matthew S McNeill
2 joint publications
Sarah F Beaudoin
1 joint publications
Kevin P Campbell
1 joint publications
Kevin M Wright
1 joint publications
Ashley M Jacobi
